Trial Profile
A Phase I trial of AR1002 for treatment of colorectal cancer (CRC).
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Oct 2016
Price :
$35
*
At a glance
- Drugs AR 1002 (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 20 Oct 2016 New trial record